ArticleBMC complementary medicine and therapies2026
Isolation and characterization of endophytic bacteria from Echinacea purpurea and Calendula officinalis with antimicrobial and anticancer activities.
Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndophytic bacteria are increasingly recognized as a promising source of biologically active secondary metabolites with potential biomedical applications. This study aimed to evaluate the antimicrobial and anticancer activities of secondary metabolite extracts derived from endophytic bacteria associated with Echinacea purpura (E. purpurea) and Calendula officinalis (C. officinalis).
methodsBacterial endophytes were identified using phenotypic characterization and 16 S rRNA gene sequencing. Secondary metabolites were extracted using ethyl acetate and evaluated for antimicrobial activity using agar well diffusion and broth microdilution assays, including determination of minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum fungicidal concentration (MFC). Cytotoxic and apoptosis-inducing effects were assessed using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) and flow cytometry assays. Chemical profiling was performed using Fourier-transform infrared spectroscopy (FTIR) and gas chromatography-mass spectrometry (GC-MS).
resultsThree isolates (SM.Ep01, SM.Co01, and SM.Co05) demonstrated measurable antimicrobial activity, predominantly against Gram-positive bacteria. SEM analysis revealed structural alterations in bacterial cells following treatment. Crude metabolite extracts induced dose-dependent cytotoxicity and apoptosis in cancer cell lines. FTIR and GC-MS analyses revealed diverse functional groups and tentatively identified compounds previously associated with biological activity.
conclusionThese findings provide preliminary evidence that endophytic bacteria associated with E. purpurea and C. officinalis may represent potential sources of biologically active metabolites.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.